PT1014943E - Formulacoes medicinais de aerossois - Google Patents

Formulacoes medicinais de aerossois

Info

Publication number
PT1014943E
PT1014943E PT98900837T PT98900837T PT1014943E PT 1014943 E PT1014943 E PT 1014943E PT 98900837 T PT98900837 T PT 98900837T PT 98900837 T PT98900837 T PT 98900837T PT 1014943 E PT1014943 E PT 1014943E
Authority
PT
Portugal
Prior art keywords
hydrofluoroalkanes
carbon dioxide
active compounds
pressure
aerosols
Prior art date
Application number
PT98900837T
Other languages
English (en)
Portuguese (pt)
Inventor
Keller Dr Manfred
Kurt Herzog
Original Assignee
Jago Res Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jago Res Ag filed Critical Jago Res Ag
Publication of PT1014943E publication Critical patent/PT1014943E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT98900837T 1997-02-05 1998-02-02 Formulacoes medicinais de aerossois PT1014943E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH24897 1997-02-05

Publications (1)

Publication Number Publication Date
PT1014943E true PT1014943E (pt) 2002-11-29

Family

ID=4182679

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98900837T PT1014943E (pt) 1997-02-05 1998-02-02 Formulacoes medicinais de aerossois

Country Status (14)

Country Link
US (1) US6461591B1 (fr)
EP (1) EP1014943B1 (fr)
JP (1) JP2001511160A (fr)
AT (1) ATE219355T1 (fr)
AU (1) AU718967B2 (fr)
CA (1) CA2280099C (fr)
DE (1) DE59804534D1 (fr)
DK (1) DK1014943T3 (fr)
ES (1) ES2178817T3 (fr)
NO (1) NO993773L (fr)
NZ (1) NZ337065A (fr)
PT (1) PT1014943E (fr)
WO (1) WO1998034595A1 (fr)
ZA (1) ZA98937B (fr)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
GB2326334A (en) † 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6218353B1 (en) * 1997-08-27 2001-04-17 Micell Technologies, Inc. Solid particulate propellant systems and aerosol containers employing the same
US6200352B1 (en) 1997-08-27 2001-03-13 Micell Technologies, Inc. Dry cleaning methods and compositions
US20040136914A1 (en) 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
NZ509328A (en) * 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
CA2347856C (fr) * 1998-11-13 2009-02-17 Jago Research Ag Poudre seche pour inhalation
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
GB9908921D0 (en) * 1999-04-19 1999-06-16 Britannia Pharmaceuticals Ltd Spray dispenser for opiod antagonists
EP1175204A4 (fr) * 1999-05-04 2006-05-31 Aradigm Corp Formulations d'aerosol et dispositifs destines a augmenter la libido chez la femme par l'administration aigue de testosterone
US7258850B2 (en) 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
FR2798290B1 (fr) * 1999-09-11 2003-09-12 Glaxo Group Ltd Formulation pharmaceutique de propionate de fluticasone
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
GB9928578D0 (en) * 1999-12-03 2000-02-02 Zeneca Ltd Pharmaceutical formulations
US20030032632A1 (en) * 1999-12-24 2003-02-13 Crispps Leslie Alan Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
US6248136B1 (en) 2000-02-03 2001-06-19 Micell Technologies, Inc. Methods for carbon dioxide dry cleaning with integrated distribution
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
SK286694B6 (sk) * 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
GB0100560D0 (en) * 2001-01-09 2001-02-21 Lamination Technologies Ltd Clothing
EP1372608B1 (fr) * 2001-03-30 2007-10-10 Jagotec Ag Formulations aerosol medicales
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
CA2446904A1 (fr) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Administration d'esters medicamenteux par inhalation
US6759029B2 (en) 2001-05-24 2004-07-06 Alexza Molecular Delivery Corporation Delivery of rizatriptan and zolmitriptan through an inhalation route
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
AU2002363947A1 (en) 2001-11-21 2003-07-24 Alexza Molecular Delivery Corporation Delivery of caffeine through an inhalation route
EP1340503A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formule d'une solution pour aerosol contenant des dérivés d'esters de 3,17 estratrien pour administration pulmonale
PT3494995T (pt) 2002-03-01 2020-03-30 Chiesi Farm Spa Formulação superfina de formoterol
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
SI1531794T1 (sl) * 2002-06-28 2017-12-29 Civitas Therapeteutics, Inc. Epinefrin za vdihavanje
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
JP2006514633A (ja) * 2002-11-26 2006-05-11 アレックザ ファーマシューティカルズ， インコーポレイテッド 吸入によって送達される抗精神病薬を用いた頭痛の治療
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
CA2507159A1 (fr) 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Utilisation de loxapine et de amoxapine pour la fabrication d'un analgesique
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
EP1569681A1 (fr) * 2002-12-13 2005-09-07 Otsuka Pharmaceutical Co., Ltd. Composition a l'interferon gammad lyophilisee, destinee a etre administree par voie pulmonaire, et systeme d'inhalation afferent
GB0229714D0 (en) * 2002-12-20 2003-01-29 Glaxo Group Ltd Novel apparatus and method
DE10260882B4 (de) * 2002-12-24 2007-02-08 IG Sprühtechnik GmbH & Co. KG Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung
WO2004075874A1 (fr) * 2003-02-28 2004-09-10 Anbics Patents-Licences Ag Procede de traitement et de prevention des infections aigues et chroniques des voies aeriennes par pseudomonas aeruginosa au moyen de macrolides pouvant etre inhales
CA2526475A1 (fr) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Unite de chauffage autonome a allumage optique ou electrique, et unite d'administration de medicament utilisant cette unite de chauffage
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050043343A1 (en) * 2003-07-28 2005-02-24 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
US11324698B2 (en) 2003-08-28 2022-05-10 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
US8846079B1 (en) * 2004-12-01 2014-09-30 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
US20060115523A1 (en) * 2004-12-01 2006-06-01 Konduri Kameswari S Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal
WO2005032521A2 (fr) * 2003-10-02 2005-04-14 Collegium Pharmaceutical, Inc. Aerosols liquides anesthesiants topiques ininflammables
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1595531A1 (fr) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression
US20050238632A1 (en) * 2004-04-23 2005-10-27 Alburty David S Propellant formulations
WO2005115336A2 (fr) * 2004-05-15 2005-12-08 Collegium Pharmaceutical, Inc. Formulations pulverisables destinees au traitement d'etats dermiques inflammatoires aigus
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006076222A2 (fr) * 2005-01-10 2006-07-20 Glaxo Group Limited Formulations pharmaceutiques
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
TR201807714T4 (tr) * 2006-02-10 2018-06-21 Pari Pharma Gmbh İnhalasyon tedavisine yönelik nebülize antibiyotikler.
US20080269347A1 (en) * 2006-09-28 2008-10-30 Azopharma, Inc. Epinephrine formulations
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
JP2010526822A (ja) * 2007-05-07 2010-08-05 クエスター ファーマシューティカルズ，インク． ベンゾジアゼピン類の経鼻投与
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
ES2586032T3 (es) 2008-03-28 2016-10-11 Hale Biopharma Ventures, Llc Administración de composiciones de benzodiazepinas
AU2010260513A1 (en) * 2009-06-16 2012-02-02 Wen Tan Use of R-Bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
TWI399202B (zh) * 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
GB201108039D0 (en) 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
WO2012174158A2 (fr) 2011-06-14 2012-12-20 Hale Biopharma Ventures, Llc Administration de benzodiazépine
US9241904B1 (en) 2011-08-19 2016-01-26 Intech Biopharm Ltd. Method for preparing metered dose sprayed inhaler for treating respiratory disease
US10034857B2 (en) 2015-07-02 2018-07-31 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery
BR122020022602B1 (pt) 2015-12-04 2024-03-05 Mexichem Fluor S.A. De C.V. Composição farmacêutica
GB201702407D0 (en) 2017-02-14 2017-03-29 Norton (Waterford) Ltd Inhalers and related methods
US20200268706A1 (en) * 2017-02-27 2020-08-27 Gregory LEVITIN Combination of furosemide and steroids and application system therefor
US20180243257A1 (en) * 2017-02-27 2018-08-30 Gregory LEVITIN Combination of furosemide and steroids and uses therefor
GB2592376A (en) * 2020-02-25 2021-09-01 Aer Beatha Ltd Canister

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (fr) 1956-03-21 1900-01-01
BE556587A (fr) 1957-01-31 1957-04-11
US4139617A (en) 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
NL7708731A (nl) 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CA1075854A (fr) * 1976-08-16 1980-04-22 Charles W. Simons Agents propulseurs aerosol pour produits a usage personnel
JPS61158919A (ja) * 1984-12-28 1986-07-18 Taisho Pharmaceut Co Ltd 水虫治療剤
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
SK392592A3 (en) 1990-06-29 1994-07-06 Fisons Plc Pressure aerosol composition
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES1018186Y (es) 1991-05-17 1992-08-16 Cano Rodriguez Andres Soporte para un iman terapeutico.
SG42375A1 (en) 1991-12-31 2001-04-17 Solvay Medicinal aerosol formulation
SE523661C2 (sv) * 1992-02-05 2004-05-04 American Pacific Corp Gas-vätskeblandning avsedd för användning som brandsläckningsmedel
WO1993017335A1 (fr) 1992-02-24 1993-09-02 Triton Diagnostics, Inc. Essai immunologique a pont
US5301664A (en) * 1992-03-06 1994-04-12 Sievers Robert E Methods and apparatus for drug delivery using supercritical solutions
GB9214765D0 (en) * 1992-07-11 1992-08-26 Smithkline Beecham Plc Pressurised aerosol formulation
WO1994003056A1 (fr) * 1992-07-31 1994-02-17 Ian Alexander Edwin Maccormick Composition insecticide en aerosol
MX9704550A (es) * 1994-12-22 1997-10-31 Astra Ab Formulaciones de medicamentos en aerosol.

Also Published As

Publication number Publication date
CA2280099A1 (fr) 1998-08-13
CA2280099C (fr) 2005-12-27
NO993773L (no) 1999-10-04
JP2001511160A (ja) 2001-08-07
NO993773D0 (no) 1999-08-04
AU5649698A (en) 1998-08-26
NZ337065A (en) 2001-02-23
US6461591B1 (en) 2002-10-08
EP1014943A1 (fr) 2000-07-05
ES2178817T3 (es) 2003-01-01
AU718967B2 (en) 2000-05-04
EP1014943B1 (fr) 2002-06-19
ATE219355T1 (de) 2002-07-15
DK1014943T3 (da) 2002-10-14
WO1998034595A1 (fr) 1998-08-13
DE59804534D1 (de) 2002-07-25
ZA98937B (en) 1998-08-06

Similar Documents

Publication Publication Date Title
PT1014943E (pt) Formulacoes medicinais de aerossois
NO20010391L (no) Medisinske aerosolformuleringer
IL153726A0 (en) Novel aerosol formulation containing a polar fluorinated molecule
MY121789A (en) Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage
DE60001492D1 (de) Pharmazeutische aerosolformulierung
GB2288978B (en) Hydrocarbon inhalant solutions stabilised by organic or inorganic acids
DE69208660D1 (de) Fluorchlorkohlenwasserstoffreie aerosolformulierungen
MY119074A (en) Pharmaceutical aerosol composition
AP2000001961A0 (en) Pharmaceutical aerosol formulation.
DE60308997D1 (de) Formulierungen zur inhalation
ATE164864T1 (de) Flüssiges kohlendioxid enthaltende treibmittel
BR9712125A (pt) Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente
MA26392A1 (fr) Respirateur aerosol
CA2355651A1 (fr) Formulations pharmaceutiques en aerosols contenant des fluoroalcanes et du budesonide
ES2159148T3 (es) Formulaciones en aerosol de furoato de mometasona libres de clorofluorocarbonos.
MX9301410A (es) Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines.
WO1999024016A8 (fr) Emulsions pour administration par dispersion aerosol et administration de medicaments